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The effects of X-rays and WR-2721 ((S)-2-/3-aminopropylamino/ethylphosphorothioic acid) on hematopoietic injury 
and recovery were studied. Adult male Swiss mice were either whole-body X-irradiated or treated with WR-2721 be-
fore X-ray exposure. The in vivo endogenous spleen colony-forming unit assay was used. The grossly visible spleen 
colonies were counted and their areas were determined on the 12th day following X-irradiation only or pre-treatment 
of mice with WR-2721. Pre-irradiation administration of WR-2721 appeared to be effective in increasing hemato-
poietic stem cell survival. The effective protection of WR-2721 against X-ray induced radiotoxicity in the mouse 
hematopoietic system was shown. 
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INTRODUCTION
The hematopoietic system is well known for its high 
sensitivity to ionizing radiation.  Cytotoxicity of io-
nizing radiation on normal hematopoietic cells is 
an important problem (YOKOMICHI, 1972; MAC VITTIE, 
1997; DEVI, 2003; SINGH et al., 2011). Therefore, a 
wide range of different compounds have been tested 
in experimental models to overcome the deleterious 
effects of ionizing radiation on hematopoietic cells 
(GUPTA et al., 2008; HAE et al., 2008; MANTENA et al., 
2008a, 2008b). Walter Reed (WR)-2721 is one of 
the cytoprotective agents used against radiation-
induced injury (HOSPERS et al., 1999; MAZUR, 2002; 
HOGLE, 2007; KOUVARIS et al. 2007).
Hematopoietic recovery depends on the per-
centage of residual hematopopietic stem cells. It 
is accepted that formation of endogenous spleen 
colonies is an indicator of hematopoietic stem 
cell proliferation.  The hematopoietic recovery oc-
curring after exposure of an organism to ionizing 
irradiation can be measured by the endogenous 
spleen colony-forming unit (E-CFUs) assay. The 
day 12 endogenous spleen colony formation in 
irradiated mice is used as a short-term quanti-
tative in vivo assay for pluripotent hematopoietic 
stem cells (PATCHEN et al., 1990; SANDEEP and NAIR, 
2011).
The present study was undertaken to determi-
ne the effects of WR-2721 and ionizing radiation 
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on the mouse hematopoietic system. A possible 
infl uence of WR-2721 on the enhancement of he-
matopoietic reconstitution, following exposure of 
mice to X-rays, was analyzed.
MATERIALS AND METHODS
Animals
The adult male Swiss mice (Animal Breeding Unit, 
Cracow) employed in the experiments weighed 
from 27 to 30 g. All the mice were kept under 
constant environmental conditions with a 12/12 
light/dark cycle. They were fed standard granula-
ted chow and given drinking water ad libitum.
Exposure to X-rays
The mice were whole-body X-ray-irradiated, using 
a TUR-250 Roentgen apparatus (Institute of Nu-
clear Physics, Cracow). Irradiation conditions: 250 
kV; 10 mA; exposure rate – 1.23 Gy/min, target di-
stance – 448 mm; fi lters – 0.5 mm Cu, 0.5 mm Al. 
During exposure to a single dose of X-rays, the ani-
mals were placed in a well-ventilated acrylic box.
WR-2721 application
(S)-2-/3-aminopropylamino/ethylphosphorothioic
acid (WR-2721, Amifostine) obtained from the In-
stitute of General Chemistry, Warsaw Agricultural 
University, was dissolved in aqua pro injectione. 
The solutions of WR-2721 were freshly prepared, 
directly before treatment of mice. The intraperito-
neal route of application was used in the experi-
ments. The injected volume of the aminothiol so-
lution was 200 μl per mouse. 
Doses of X-rays and WR-2721
The mice were exposed to X-rays only, and trea-
ted with WR-2721 prior to X-irradiation, always at 
about 10.00 a.m. The mice were irradiated with 
sublethal and lethal single doses of X-rays from 5 
Gy to 17 Gy. The aminothiol was given at a single 
dose of 400 mg/kg body weight, 30 min prior to 
exposure of mice to X-rays. This dose of WR-2721 
represents two-thirds of the toxic LD50 lethal dose. 
The dose of the aminothiol given in the present 
investigations and the time interval between WR-
2721 administration and irradiation coincide with 
those most often used in radioprotection (SANTINI 
and GILES, 1999; MAZUR, 2000; MAZUR et al., 2003).
Mortality of mice
The mortality of mice was analyzed during the 12-
day period. The lethal dose (LD50/12) for mice X-ir-
radiated only and those pretreated with WR-2721 
was determined and the dose reduction factor 
(DRF) was calculated.
Spleen colony assay
Twelve days following X-irradiation, and WR-2721 
application before exposure to X-rays, the mice 
were euthanized by cervical dislocation. Their 
spleens were removed, fi xed in Bouin’s solution, 
and the grossly visible spleen colonies were coun-
ted. For morphometric studies, thin 4–5 μm sec-
tions of the spleens were prepared. These spleen 
sections were stained with hematoxylin and eosin. 
Using light microscopy and IBM Computer Scan-
ning Systems, the areas of both the spleen and 
the formed endogenous spleen colonies were as-
sessed. The ratio of the E-CFUs area to the spleen 
area was determined. The dose modifying factor 
(DMF) was calculated.
Statistical evaluation
Statistical signifi cance of alterations in the num-
ber of E-CFUs between the particular groups of 
mice was evaluated by the analysis of variance 
and Duncan’s new multiple range test.
RESULTS
The mortality of adult male Swiss mice exposed 
to X-irradiation only and those pre-treated with 
WR-2721 was determined (Table 2). The value of 
LD50/12 for mice X-irradiated only and those treated 
with WR-2721 before irradiation was 7.4 Gy and 
17 Gy, respectively. The value of DRF was 2.30. 
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The effects of X-rays and WR-2721 applied 
prior to the exposure of mice to X-irradiation on 
the day 12 endogenous spleen colony formation 
were assessed (Table 1, Table 2, Fig.1). The day 12 
E-CFUs formed in the spleens were shown (Fig.1).
The confl uent spleen colonies were observed in 
mice exposed to 5 Gy and 6 Gy X-rays and in those 
treated with WR-2721 prior to X-irradiation at a 
single dose of 5 Gy, 6 Gy, 7 Gy, 8 Gy, 9 Gy, 10 Gy 
and 11 Gy. The greatest number of the grossly vi-
sible E-CFUs was found in mice exposed to X-rays 
only, at a dose of 7 Gy. Among mice pre-treated 
with WR-2721, the greatest number of the grossly 
visible endogenous spleen colonies was observed 
after the exposure of mice to 12 Gy X-rays, and de-
clined with the increasing X-ray doses. The num-
ber of E-CFUs was greater in mice exposed to 7 Gy 
X-rays only than in those treated with both WR-
2721 and 12 Gy X-rays.  The number of the grossly 
***  not done
Statistically signifi cant differences at P<0.05
Differences between groups of mice: 
different from group of mice exposed to X-rays at a dose of  7 Gy – 7; 
8 Gy – 8; 
different from group of mice treated with WR-2721 prior to X-irradia-
tion,  at a dose of 12 Gy – 12; 13 Gy – 13; 14 Gy – 14; 15 Gy  – 15; 
16 Gy – 16.
X-ray-dose
(Gy)
X-rays WR-2721  +  X-rays
Number of E-CFUs Number of E-CFUs
5 confl uent confl uent
6 confl uent confl uent
7 8, 12, 13, 14, 15, 16        19.62 ± 2.77 confl uent
8   7, 12, 13, 14, 15        2.17 ± 0.41 confl uent
9 *** confl uent
10 *** confl uent
11 *** confl uent
12 ***  7, 8, 13, 14, 15, 16        15.80 ± 3.70
13 ***  7, 8, 12, 14, 15, 16        12.75 ± 2.22
14 ***  7, 8, 12, 13, 15, 16          9.33 ± 2.58
15 ***  7, 8, 12, 13, 14, 16            6.29 ± 1.25
16 ***      7, 12, 13, 14, 15            2.20 ± 0.45
TABLE 1. The effects of WR-2721 on the endogenous spleen 
colony formation in X-irradiated mice.
TABLE 2. The mouse mortality and the ratio of E-CFUs area 
to the spleen area in mice exposed to X-rays only and those 
treated with WR-2721 prior to X-irradiation.
Fig. 1. The endogenous spleen colonies visible on the 12th 




E-CFU area / 
spleen area
(x 102)
7 Gy X-rays 21.43 39.37
8 Gy X-rays 62.50  5.87
WR-2721  +  12 Gy   0.00 26.51
WR-2721  +  13 Gy   0.00 17.91
WR-2721  +  14 Gy 16.00 13.94
WR-2721  +  15 Gy 25.00 10.47
WR-2721  +  16 Gy 37.00   5.78
visible E-CFUs found for mice X-irradiated only, 
at a dose of 8 Gy, was similar to that observed for 
the animals given WR-2721 prior to 16 Gy X-ray 
exposure. The patterns of changes in the ratio of 
the E-CFUs area to the spleen area appeared to be 
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similar to the patterns of alterations in the number 
of E-CFUs observed on the 12th day after X-irra-
diation alone and WR-2721 administration prior to 
X-ray treatment of mice. Based on the data of the 
present study, the obtained value of DMF was 2. 
DISCUSSION
The results of the study have shown the effects of 
WR-2721 and X-rays on the mortality and the he-
matopoietic system of adult male Swiss mice, using 
LD50/12 assay and the day 12 endogenous spleen 
colony forming unit assay. WR-2721, when given 
at a single dose of 400 mg/kg body weight, 30 min 
before X-irradiation, reduced the deleterious X-ray 
action on the mouse organism. The administration 
of WR-2721 before the lethal doses of X-irradiation 
enhanced survival of Swiss mice. Based on E-CFUs 
formation, it has been found that pre-irradiation 
application of WR-2721 enhanced hematopoietic re-
constitution in X-irradiated mice. WR-2721 distin-
ctly increased both the number of endogenous plu-
ripotent hematopoietic stem cells and the area of the 
formed endogenous spleen colonies in mice exposed 
to the sublethal and lethal doses of X-rays. The ra-
dioprotective properties of WR-2721 against X-ray 
irradiation of Swiss mice have been demonstrated. 
The mechanisms of action of WR-2721 on nor-
mal cells have not yet been completely elucidated. 
It is known that WR-2721 is a phosphorylated pro-
drug and its radioprotective action requires conver-
sion to the active, free thiol compound WR-1065 
(2-3/aminopropylamino/ethanothiol). WR-1065 is 
subsequently oxidized to the symmetric disulfi de 
WR-33278. Various mechanisms or a combination 
of mechanisms of the radioprotective action of WR-
2721 have been proposed: at the molecular level, 
by free radical scavenging, hydrogen donation, 
binding to critical biological targets, and mixed 
disulphide formation with endogenous thiols and 
thiol-containing proteins; at the biochemical-phy-
siological level, by hypoxia, biochemical shock, and 
hypothermia, and at the organ level, by stimulation 
of cell population recovery (GRIGGS, 1998; CASTIGLIONE 
et al., 1999; SANTINI and GILES, 1999; MAZUR, 2002).
The results of the present investigations have 
shown the effective radioprotection by WR-2721 
against X-ray-induced injury to the mouse hema-
topoietic system. A better understanding of the ra-
dioprotective action of WR-2721 on hematopoietic 
cells is of key importance in cell biology, hemato-
logy, and radiotherapy.
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